Positive correlation with tumor relapse and metastasis after chemotherapy in breast cancer (48) and correlation with worse clinical prognosis in OSCC (49).Increased amount of CD206+TAMs associated with improved overall survival in cutaneous melanoma (47). This evidence concerns the gene MRC1 and breast carcinoma.